IRIS
DANESE, Silvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.316
AS - Asia 16.179
EU - Europa 5.785
SA - Sud America 3.159
AF - Africa 851
Continente sconosciuto - Info sul continente non disponibili 765
OC - Oceania 57
AN - Antartide 1
Totale 58.113
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.676
SG - Singapore 10.287
BR - Brasile 2.611
CN - Cina 2.432
VN - Vietnam 1.562
IT - Italia 1.279
FI - Finlandia 1.022
IE - Irlanda 719
NG - Nigeria 594
DE - Germania 557
FR - Francia 481
HK - Hong Kong 437
GB - Regno Unito 404
CA - Canada 393
IN - India 263
NL - Olanda 255
SE - Svezia 209
AR - Argentina 196
BD - Bangladesh 174
TR - Turchia 173
RU - Federazione Russa 146
MX - Messico 130
IQ - Iraq 119
ES - Italia 105
BE - Belgio 100
PL - Polonia 93
UA - Ucraina 86
JP - Giappone 84
IL - Israele 83
EC - Ecuador 82
ZA - Sudafrica 82
ID - Indonesia 72
CL - Cile 66
CO - Colombia 60
RO - Romania 59
PK - Pakistan 52
VE - Venezuela 52
SA - Arabia Saudita 48
AU - Australia 47
PH - Filippine 42
A2 - ???statistics.table.value.countryCode.A2??? 41
PY - Paraguay 39
EG - Egitto 38
UZ - Uzbekistan 38
CZ - Repubblica Ceca 36
MA - Marocco 36
GR - Grecia 34
MY - Malesia 31
JO - Giordania 30
IR - Iran 28
AE - Emirati Arabi Uniti 27
LT - Lituania 27
NP - Nepal 25
KR - Corea 23
CR - Costa Rica 22
AT - Austria 21
CH - Svizzera 21
DZ - Algeria 21
JM - Giamaica 21
PE - Perù 21
TN - Tunisia 21
KE - Kenya 20
KZ - Kazakistan 20
AL - Albania 18
AZ - Azerbaigian 18
NO - Norvegia 18
UY - Uruguay 18
PT - Portogallo 16
MD - Moldavia 15
HN - Honduras 14
LB - Libano 14
DK - Danimarca 12
DO - Repubblica Dominicana 11
ET - Etiopia 11
SY - Repubblica araba siriana 11
KG - Kirghizistan 10
BO - Bolivia 9
BY - Bielorussia 9
GT - Guatemala 9
OM - Oman 9
CY - Cipro 8
PA - Panama 8
SN - Senegal 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
HU - Ungheria 7
NI - Nicaragua 7
PS - Palestinian Territory 7
NZ - Nuova Zelanda 6
TW - Taiwan 6
BN - Brunei Darussalam 5
MK - Macedonia 5
QA - Qatar 5
SI - Slovenia 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BG - Bulgaria 4
GE - Georgia 4
GY - Guiana 4
Totale 57.312
Salva come PNG Salva come JPEG
Città #
Singapore 4.909
Chandler 4.186
Wilmington 4.034
Ashburn 1.770
San Mateo 1.632
The Dalles 1.599
Ann Arbor 1.255
Dallas 1.190
Shanghai 1.134
Helsinki 1.018
San Jose 876
Council Bluffs 849
Princeton 727
Dublin 712
Lawrence 712
Leawood 702
Boardman 699
New York 616
Benin City 588
Milan 542
Ho Chi Minh City 523
Beijing 511
Hong Kong 405
Paris 404
Hanoi 403
Woodbridge 380
Fairfield 367
Santa Clara 335
Los Angeles 297
Amsterdam 237
Rome 233
São Paulo 202
Phoenix 197
Toronto 197
London 194
Columbus 173
Seattle 172
Buffalo 140
Norwalk 109
San Diego 99
Orem 96
Kocaeli 92
Rio de Janeiro 92
Brussels 90
Belo Horizonte 71
Chicago 65
Da Nang 64
Brooklyn 63
Houston 63
Warsaw 60
Haiphong 58
Falkenstein 56
Tokyo 56
Brasília 55
Atlanta 53
Montreal 49
Chennai 48
Munich 48
Campinas 47
Redwood City 47
Naples 44
Figino 41
Mexico City 41
Pune 41
Charlotte 40
Johannesburg 40
Las Vegas 40
Miami 39
San Francisco 38
Baghdad 37
Falls Church 36
Frankfurt am Main 36
Monmouth Junction 36
Moscow 36
Curitiba 34
Abbiategrasso 33
Clearwater 33
Tashkent 32
Porto Alegre 31
Cambridge 29
Manchester 29
Amman 28
Boston 28
Des Moines 28
Guayaquil 27
Biên Hòa 26
Brno 26
Mumbai 26
Philadelphia 26
Turin 26
Dhaka 25
Quito 25
Hillsboro 24
Ottawa 24
Salvador 24
Stockholm 24
Queens 23
Denver 22
Guarulhos 22
Goiânia 21
Totale 37.842
Salva come PNG Salva come JPEG
Nome #
Biological agents for ulcerative colitis : Hypes and hopes 314
Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion 278
Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial 209
Crohn's disease 173
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 169
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 157
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 152
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 149
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 147
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis 147
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 146
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 142
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 142
Endoscopic flexible treatment of Zenker's diverticulum: a modification of the needle-knife technique 136
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease 136
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis 135
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 135
Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go 135
Review article: optimal preparation for surgery in Crohn's disease 133
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 132
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 132
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 132
Bowel damage as assessed by the Lémann Index is reversible on anti-TNF therapy for Crohn's disease 131
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 130
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 129
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 128
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate 128
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 128
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 126
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 125
Adalimumab is effective in achieving clinical and endoscopic long-term deep remission : a case report 124
Intestinal microbiota in inflammatory bowel disease: Friend of foe? 124
A NEW TOOL FOR PRE-COLONOSCOPY DYING OF THE COLONIC MUCOSA WITH ORAL MULTI MATRIX RELEASE TECHNOLOGY (MMX (R))-RELEASED METHYLENE BLUE: A PRELIMINARY STUDY 124
Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease 123
Ulcerative Colitis 123
Laparoscopic Surgery for Recurrent Crohn's Disease 121
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial 121
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study. 121
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies 118
Risk of postoperative recurrence and postoperative management of Crohn's disease 118
Colitis-associated cancer: the dark side of inflammatory bowel disease 118
Methylene blue MMX (R) tablets for chromoendoscopy. Safety tolerability and bioavailability in healthy volunteers 118
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 118
Imaging Modalities for Perianal Crohn's Disease 117
Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome. 117
Inflammatory bowel disease: the role of environmental factors 116
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 115
Accuracy of Diffusion-weighted Magnetic Resonance Imaging in Detecting Mucosal Healing and Treatment Response, and in Predicting Surgery, in Crohn's Disease 115
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study 114
Perception of reproductive health in women with inflammatory bowel disease 114
Adalimumab in active ulcerative colitis: A "real-life" observational study 114
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 112
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2 112
PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD 112
Biological therapies for inflammatory bowel disease: Research drives clinics 111
Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice 111
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 111
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 110
Second-Generation Corticosteroids for the Treatment of Crohn's Disease and Ulcerative Colitis: More Effective and Less Side Effects? 110
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease 110
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 110
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis 110
Immune regulation by microvascular endothelial cells: Directing innate and adaptive immunity, coagulation, and inflammation 109
Accuracy of a new diagnostic tool in deep infiltrating endometriosis: Positron emission tomography-computed tomography with 16 alpha-[18F]fluoro-17 beta-estradiol 109
Management of IBD during the COVID-19 outbreak: resetting clinical priorities 109
Emerging biologics in the treatment of inflammatory bowel disease : what is around the corner? 108
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients 108
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 108
A Multidisciplinary Approach to Rectal Cancer Treatment in Ulcerative Colitis Results in High Rate of Restorative Minimally Invasive Surgery 107
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 107
Development and validation of the Nancy histological index for UC 107
Endoscopic mucosal resection for early colorectal neoplasia: pathologic basis, procedures, and outcomes. 107
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization 107
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy 107
Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment 106
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 106
Evolving strategies and goals of treatment in ulcerative colitis 105
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 105
Surgical rates in the era of biological therapy: up, down or unchanged? 104
Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer 104
A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX® for mild-to-moderate ulcerative colitis 104
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study 103
IBD Of mice and men-shedding new light on IL-13 activity in IBD 103
Impact of Medications on Radiologic Disease Activity and Bowel Damage in Crohn's Disease: A Prospective Longitudinal MRI Study 103
Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis Associations 103
Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease 103
Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications 103
Balanced Propofol Sedation (BPS) Administered by Non-Anesthesiologists vs Midazolam Alone for Endoscopic Procedure in Patients With IBD: A Single Center Open-Label Trial 103
Regulation of leukocyte recruitment by the long pentraxin PTX3. 103
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease 102
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease 102
A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX® FOR MILD-TO-MODERATE ULCERATIVE COLITIS 102
Dysregulated intracellular redox equilibrium in intestinal lamina propria T cells (LPT) contributes to mucosal inflammation 101
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease 101
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter? 100
Review article: causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-alpha therapy 100
Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease 100
Methotrexate for Corticosteroid- Dependent Ulcerative Colitis: Results of a Placebo Randomized Controlled Trial 100
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis 100
Effect of tumour necrosis factor antagonists on avoiding surgery in stricturing Crohn's disease: a tertiary centre real-life experience 100
Totale 12.227
Salva come PNG Salva come JPEG
Categoria #
all - tutte 397.458
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 397.458
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.046 0 0 132 869 39 48 127 554 391 708 943 235
2022/202310.508 1.606 443 1.059 1.207 896 952 32 939 1.827 865 553 129
2023/20245.131 439 529 1.152 220 179 613 231 276 98 89 425 880
2024/20257.671 223 196 74 214 228 939 357 975 984 1.836 811 834
2025/202619.599 2.911 1.131 1.322 1.818 576 645 5.910 1.045 1.063 1.153 635 1.390
2026/20273.375 1.606 1.739 30 0 0 0 0 0 0 0 0 0
Totale 58.113